| 臺大學術典藏 |
2022-08-19T00:21:05Z |
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
|
Chen K.-F.; Yeh P.-Y.; CHIUN HSU; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; Chen P.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:51:21Z |
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
|
Chen K.-F.; Yeh P.-Y.; Chiun Hsu; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; Chen P.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2021-07-03T03:34:50Z |
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
|
Chen K.-F.; Yeh P.-Y.; Hsu C.; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; PEI-JER CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-01T01:54:22Z |
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
|
Chen K.-F.; Yeh P.-Y.; Hsu C.; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; Chen P.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:30:05Z |
Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A
|
Chen, K.-F. Yu, H.-C. Liu, C.-Y. Chen, H.-J. Chen, Y.-C. Hou, D.-R. Chen, P.-J. Cheng, A.-L.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2021-07-03T03:34:38Z |
Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A
|
Chen K.-F.; Yu H.-C.; Liu C.-Y.; Chen H.-J.; Chen Y.-C.; Hou D.-R.; PEI-JER CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-01T01:54:10Z |
Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A
|
Chen K.-F.; Yu H.-C.; Liu C.-Y.; Chen H.-J.; Chen Y.-C.; Hou D.-R.; Chen P.-J.; ANN-LII CHENG |
| 國家衛生研究院 |
2010-01-30 |
Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B
|
Ko, BS;Chang, TC;Chen, CH;Liu, CC;Kuo, CC;Hsu, C;Shen, YC;Shen, TL;Golubovskaya, VM;Chang, CC;Shyue, SK;Liou, JY |
| 臺大學術典藏 |
2022-08-19T00:21:04Z |
Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B
|
Liou J.-Y.; Shyue S.-K.; Chang C.-C.; Golubovskaya V.M.; Shen T.-L.; Shen Y.-C.; CHIUN HSU; Kuo C.-C.; Ko B.-S.; Chang T.-C.; Chen C.-H.; Liu C.-C. |
| 國立臺灣大學 |
2010-12 |
Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B
|
Ko, Bor-Sheng; Chang, Tzu-Ching; Chen, Chien-Hung; Liu, Chia-Chia; Liang, Shu-Man; Hsing, En-Wei; Kuo, Cheng-Chin; Hsu, Chiun; Shen, Ying-Chun; Shen, Tang-Long; Shyue, Song-Kun; Golubovskaya, Vita M.; Chang, Chung-Che; Liou, Jun-Yang |
| 國立臺灣大學 |
2010 |
Bortezomib Suppresses Focal Adhesion Kinase Expression Via Interrupting Nuclear Factor-Kappa B
|
柯博升; 張孜菁; 陳建宏; 劉佳佳; 郭呈欽; 許駿; 沈盈君; 沈湯龍; 徐松錕; 劉俊揚; KO, BO-SHENG; CHANG, TZU-CHING; CHEN, CHIEN- HUNG; LIU, CHIA-CHIA; KUO, CHENG-CHIN; HSU, CHIUN; SHEN, YING-CHUN; SHEN, TANG-LONG; SHYUE, SONG-KUN; LIOU, JUN-YANG |
| 臺大學術典藏 |
2020-04-10T12:51:20Z |
Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B
|
Ko B.-S.;Chang T.-C.;Chen C.-H.;Liu C.-C.;Kuo C.-C.;Chiun Hsu;Shen Y.-C.;Shen T.-L.;Golubovskaya V.M.;Chang C.-C.;Shyue S.-K.;Liou J.-Y.; Ko B.-S.; Chang T.-C.; Chen C.-H.; Liu C.-C.; Kuo C.-C.; Chiun Hsu; Shen Y.-C.; Shen T.-L.; Golubovskaya V.M.; Chang C.-C.; Shyue S.-K.; Liou J.-Y. |
| 臺大學術典藏 |
2021-03-09T05:18:37Z |
Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B
|
Ko B.-S.; Chang T.-C.; Chen C.-H.; Liu C.-C.; Kuo C.-C.; Hsu C.; Ying-Chun Shen; Shen T.-L.; Golubovskaya V.M.; Chang C.-C.; Shyue S.-K.; Liou J.-Y. |
| 臺大學術典藏 |
2021-01-12T12:53:47Z |
Bortezomib therapy in a real-world setting in patients with relapsed or refractory multiple myeloma
|
SHANG-YI HUANG; Chen T.-Y.; Kuo C.-Y.; Chen Y.-C.; Lin S.-F.; Chang M.-C.; Lv X.; Yang B.; Chang C.-S. |
| 國立成功大學 |
2019 |
Bortezomib therapy in a real-world setting in patients with relapsed or refractory multiple myeloma
|
Huang, S.-Y.;Chen, T.-Y.;Kuo, C.-Y.;Chen, Y.-C.;Lin, S.-F.;Chang, M.-C.;Lv, X.;Yang, B.;Chang, Chang C.-S. |
| 國立成功大學 |
2022-06-17 |
Bortezomib 在小鼠模型中降低增殖性玻璃體視網膜病變的嚴重性
|
劉思琪; Liu, Szu-Chi |
| 國立成功大學 |
2017-11 |
Bortezomib-induced miRNAs direct epigenetic silencing of locus genes and trigger apoptosis in leukemia
|
Chu;Yu-Yi;Ko;Chiung-Yuan;Wang;Shao-Ming;Lin;Pin-I;Wang;Han-Ying;Lin;Wen-Chi;Wu;Dong-Yu;Wang;Lu-Hao;Wang;Ju-Ming |
| 臺北醫學大學 |
2010 |
Bortezomib誘導人類Burkitt淋巴癌細胞異質性核蛋白K 之SUMOylation分子機制探討
|
廖晏如 |
| 元智大學 |
2019-12-05 |
Borylated Compounds with Thermally Activated Delayed Fluorescence and OLED Performance
|
Yi-Fan Lin; Yeh-Hsiang Tseng; Yen-Chia Cheng; Chih-Hao Chang*; Hsin-Yun Chih; Ying-Wei Chen; Chih-Chieh Tsai; Chin-Wei Lu* |
| 元智大學 |
2019-12-05 |
Borylated Compounds with Thermally Activated Delayed Fluorescence and OLED Performance
|
Yi-Fan Lin; Yeh-Hsiang Tseng; Yen-Chia Cheng; Chih-Hao Chang*; Hsin-Yun Chih; Ying-Wei Chen; Chih-Chieh Tsai; Chin-Wei Lu* |
| 元智大學 |
2019-12-05 |
Borylated Compounds with Thermally Activated Delayed Fluorescence and OLED Performance
|
Yi-Fan Lin; Yeh-Hsiang Tseng; Yen-Chia Cheng; Chih-Hao Chang*; Hsin-Yun Chih; Ying-Wei Chen; Chih-Chieh Tsai; Chin-Wei Lu* |
| 臺大學術典藏 |
2018-09-10T08:40:07Z |
Borylene - boron bearing a negative charge
|
Lai, C.-H.; Chou, P.-T.; PI-TAI CHOU |
| 淡江大學 |
Panel K / 24 June / 3:30-5:00 |
Bos and Equus in poems by Susan Hawthorne and Peter Skrzynecki
|
Ralph, Iris |
| 淡江大學 |
1999-12-20 |
Bose condensation and electron pairing in one-dimensional Hubbard model
|
Kocharian, A. N.; 楊棨; Yang, Chi; Chiang, Y. L. |
| 臺大學術典藏 |
2017 |
Bose-Einstein condensation of triplons in the S=1 tetramer antiferromagnet K2Ni2(MoO4)3: A compound close to a quantum critical point
|
Skourski, Y.; Baenitz, M.; Koteswararao, B.; Khuntia, P.; Kumar, R.; Mahajan, A. V.; Yogi, A.; Chou, F. C. |
